Clinical trial

Oral Anti Diabetic Agents in the Hospital

NCT04416269

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2020-08-07

PhasePHASE4

Study timeline

Study start (actual)2020-08-07Date precision: day

Registry last updated2026-08-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusunresolved

Interventions

Oral Anti-diabetes Drugs aloneDRUG

Basal bolus insulinDRUG

Supplemental insulinDRUG

Continuous glucose monitoring (CGM)DEVICE

Sponsors & collaborators

Emory Universitylead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

AtlantaGeorgia, United States3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04416269 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.